In 2023, the import volume of cortisone, hydrocortisone, prednisone, and prednisolone to India stood at 64.2 thousand kilograms. The forecast from 2024 to 2028 shows a steady annual increase, with volumes rising from 65.51 to 71.17 thousand kilograms. The year-on-year growth from 2024 to 2025 is 2.23%, continuing similarly through the forecast period. The compound annual growth rate (CAGR) over the five-year period from 2024 to 2028 is anticipated to be approximately 2.13%.
Future trends to watch include potential changes in import volumes influenced by India's domestic pharmaceutical production capacity, regulatory changes affecting drug imports, and evolving healthcare demands driven by population growth and increased prevalence of conditions treated by these corticosteroids.
